Athersys to Participate in The American Society for Neural Therapy and Repair Annual Conference

Author's Avatar
Apr 21, 2023

Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) cell therapy for critical care indications, announced today their participation in The American Society for Neural Therapy and Repair Annual Conference from April 27-30, 2023 in Clearwater, FL.